ERBB3

Multifunctional enabler or primary actor in pancreatic cancer?

Research output: Contribution to journalArticle

2 Citations (Scopus)
Original languageEnglish
Pages (from-to)564-566
Number of pages3
JournalCancer Biology and Therapy
Volume10
Issue number6
DOIs
StatePublished - Sep 15 2010

Fingerprint

Neoplastic Gene Expression Regulation
Xenograft Model Antitumor Assays
ErbB-3 Receptor
Quinazolines
Protein Kinase Inhibitors
Tumor Burden
Tumor Cell Line
Reverse Transcriptase Polymerase Chain Reaction
Pancreatic Neoplasms
Epidermal Growth Factor Receptor
Drug Resistance
Signal Transduction
Adenocarcinoma
Western Blotting
Cell Proliferation
Erlotinib Hydrochloride

Keywords

  • Drug resistance
  • EGFR
  • ERBB3
  • Erlotinib
  • HER3
  • Pancreatic cancer

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Molecular Medicine
  • Pharmacology

Cite this

ERBB3 : Multifunctional enabler or primary actor in pancreatic cancer? / Landgraf, Ralf.

In: Cancer Biology and Therapy, Vol. 10, No. 6, 15.09.2010, p. 564-566.

Research output: Contribution to journalArticle

@article{02146f009c504770a1b694a3ebf46253,
title = "ERBB3: Multifunctional enabler or primary actor in pancreatic cancer?",
keywords = "Drug resistance, EGFR, ERBB3, Erlotinib, HER3, Pancreatic cancer",
author = "Ralf Landgraf",
year = "2010",
month = "9",
day = "15",
doi = "10.4161/cbt.10.6.12997",
language = "English",
volume = "10",
pages = "564--566",
journal = "Cancer Biology and Therapy",
issn = "1538-4047",
publisher = "Landes Bioscience",
number = "6",

}

TY - JOUR

T1 - ERBB3

T2 - Multifunctional enabler or primary actor in pancreatic cancer?

AU - Landgraf, Ralf

PY - 2010/9/15

Y1 - 2010/9/15

KW - Drug resistance

KW - EGFR

KW - ERBB3

KW - Erlotinib

KW - HER3

KW - Pancreatic cancer

UR - http://www.scopus.com/inward/record.url?scp=77957121833&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957121833&partnerID=8YFLogxK

U2 - 10.4161/cbt.10.6.12997

DO - 10.4161/cbt.10.6.12997

M3 - Article

VL - 10

SP - 564

EP - 566

JO - Cancer Biology and Therapy

JF - Cancer Biology and Therapy

SN - 1538-4047

IS - 6

ER -